New vaccine aims to tame hepatitis b virus
NCT ID NCT03038802
Summary
This early-stage study is testing a new vaccine designed to help the body fight chronic Hepatitis B infection. It will involve 40 adults with Hepatitis B to see if the vaccine is safe and can reduce the amount of virus in their blood. The ultimate goal is to help patients' immune systems better control the virus or possibly clear it entirely.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC HEPATITIS B are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
ARASMI
Adelaide, South Australia, 5046, Australia
Contact
Contact
Conditions
Explore the condition pages connected to this study.